Cargando…
Where is biological therapy going?
The substantial progress in our understanding of molecular and cellular biology has allowed us to design biological therapeutics ('biologicals') with defined targets and effector functions. These biologicals have greatly contributed to our current knowledge of pathogenetic mechanisms in au...
Autores principales: | Schulze-Koops, Hendrik, Kalden, Joachim R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC130132/ https://www.ncbi.nlm.nih.gov/pubmed/11094444 http://dx.doi.org/10.1186/ar108 |
Ejemplares similares
-
Obstacles to Anti-CD4 Therapy in Rheumatoid Arthritis
por: Kalden, Joachim R, et al.
Publicado: (2000) -
AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022) -
Breast cancer research: where we are and where we should go
por: Liu, Edison T
Publicado: (2000) -
Glucagon-Like Peptide 1 in the Brain: Where Is It Coming From, Where Is It Going?
por: Daniels, Derek, et al.
Publicado: (2019) -
Predicting Molecular Models: Where Are We Going?
por: Ratta, Raffaele, et al.
Publicado: (2015)